Darren Yuen is a Clinician Scientist and Staff Nephrologist, an Associate Professor in the Faculty of Medicine at the University of Toronto, and the Canada Research Chair in Fibrotic Injury. He completed his MD training at the University of Toronto (2002), his PhD in the lab of Dr. Richard Gilbert at the University of Toronto (2011), and his postdoctoral fellowship in the lab of Dr. Lisa Robinson at the Hospital for Sick Children (2013). He is a co-founder of Fibrocor Therapeutics, which is developing new anti-fibrotic treatments. His research group is based at St. Michael’s Hospital. Dr.

Iannis Talianidis received his diploma from the Semmelweis University Medical School in Budapest Hungary in 1981. He continued his post-graduate studies in the Department of Biochemistry of the same University, where he obtained his PhD degree in Biology. Between 1985 and 1987, he worked as a postdoctoral researcher at the Dept. of Biological Chemistry of Harvard University Medical School. He continued his postdoctoral studies at the Dept. of Chemistry of UC Berkeley until 1990, when he joined IMBB-FORTH as Group Leader. He served as Director of the IMBG at the BSRC Al.